Your browser doesn't support javascript.
loading
US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory?
Piemonti, Lorenzo; Andres, Axel; Casey, John; de Koning, Eelco; Engelse, Marten; Hilbrands, Robert; Johnson, Paul; Keymeulen, Bart; Kerr-Conte, Julie; Korsgren, Olle; Lehmann, Roger; Lundgren, Torbjörn; Maffi, Paola; Pattou, Francois; Saudek, Frantisek; Shaw, James; Scholz, Hanne; White, Steve; Berney, Thierry.
  • Piemonti L; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Andres A; Department of Surgery, Geneva University Hospitals, Geneva, Switzerland.
  • Casey J; Edinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh, UK.
  • de Koning E; Department of Internal Medicine and Transplantation Center, Leiden University Medical Center, Leiden, the Netherlands.
  • Engelse M; Department of Internal Medicine and Transplantation Center, Leiden University Medical Center, Leiden, the Netherlands.
  • Hilbrands R; Diabetes Research Center (DRC), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
  • Johnson P; Nuffield Department of Surgical Sciences and Oxford Biomedical Research Centre (OxBRC), Oxford Centre for Diabetes, Endocrinology, and Metabolism (OCDEM), University of Oxford, Oxford, UK.
  • Keymeulen B; Diabetes Research Center (DRC), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
  • Kerr-Conte J; Translational Research for Diabetes, Inserm, Centre Hospitalier Universitaire Lille, Lille Pasteur Institute, U1190, European Genomic Institute for Diabetes, University of Lille, Lille, France.
  • Korsgren O; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Lehmann R; Department Endocrinology, Diabetes and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland.
  • Lundgren T; Division of Transplantation Surgery, CLINTEC, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Maffi P; Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Pattou F; Translational Research for Diabetes, Inserm, Centre Hospitalier Universitaire Lille, Lille Pasteur Institute, U1190, European Genomic Institute for Diabetes, University of Lille, Lille, France.
  • Saudek F; Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • Shaw J; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Scholz H; Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
  • White S; Department of HPB and Transplant Surgery, The Freeman Hospital, Newcastle Upon Tyne, UK.
  • Berney T; Department of Surgery, Geneva University Hospitals, Geneva, Switzerland.
Transpl Int ; 34(7): 1182-1186, 2021 07.
Article en En | MEDLINE | ID: mdl-34048106

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Islotes Pancreáticos / Islotes Pancreáticos / Diabetes Mellitus Tipo 1 Límite: Humans País como asunto: America do norte / Asia / Europa / Oceania Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Islotes Pancreáticos / Islotes Pancreáticos / Diabetes Mellitus Tipo 1 Límite: Humans País como asunto: America do norte / Asia / Europa / Oceania Idioma: En Año: 2021 Tipo del documento: Article